{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:25:49Z","timestamp":1794014749322,"version":"4.8.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jidinnovations.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JID Innovations"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.xjidi.2022.100129","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T14:34:58Z","timestamp":1649774098000},"page":"100129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["How Do Experts Treat Patients with Bullous\u00a0Pemphigoid around the World? An\u00a0International Survey"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1891-528X","authenticated-orcid":false,"given":"Marine","family":"Guignant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7404-010X","authenticated-orcid":false,"given":"Billal","family":"Tedbirt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2971-0199","authenticated-orcid":false,"given":"Dedee F.","family":"Murrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3314-7052","authenticated-orcid":false,"given":"Masayuki","family":"Amagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4256-4413","authenticated-orcid":false,"given":"Valeria","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5624-2055","authenticated-orcid":false,"given":"Johannes","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7605-4780","authenticated-orcid":false,"given":"Giuseppe","family":"Ciancinni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7692-6446","authenticated-orcid":false,"given":"Donna","family":"Culton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1020-8895","authenticated-orcid":false,"given":"Maryam","family":"Daneshpazhooh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8682-2598","authenticated-orcid":false,"given":"Dipankar","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8203-0486","authenticated-orcid":false,"given":"Janet","family":"Fairley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7621-4935","authenticated-orcid":false,"given":"Russell","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2327-4755","authenticated-orcid":false,"given":"Soo-Chan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9785-3442","authenticated-orcid":false,"given":"Neil J.","family":"Korman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6608-9066","authenticated-orcid":false,"given":"Cezary","family":"Kowalewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7158-2085","authenticated-orcid":false,"given":"Daniel","family":"Mimouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9616-2001","authenticated-orcid":false,"given":"Aikaterini","family":"Patsatsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9071-2033","authenticated-orcid":false,"given":"Vivien","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9487-8708","authenticated-orcid":false,"given":"Marwah Adly Mohamed","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1206-8913","authenticated-orcid":false,"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4093-1032","authenticated-orcid":false,"given":"Eli","family":"Sprecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7059-5474","authenticated-orcid":false,"given":"Soner","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6880-0678","authenticated-orcid":false,"given":"Vanessa","family":"Venning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3030-5369","authenticated-orcid":false,"given":"Victoria P.","family":"Werth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5668-307X","authenticated-orcid":false,"given":"Detlef","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5734-0255","authenticated-orcid":false,"given":"Pascal","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xjidi.2022.100129_bib1","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/archderm.143.12.1536","article-title":"A\u00a0comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid","volume":"143","author":"Beissert","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","article-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0190-9622(96)80085-5","article-title":"Treatment of bullous pemphigoid with dapsone: retrospective study of thirty-six cases","volume":"34","author":"Bouscarat","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2133.2011.10413.x","article-title":"Autoimmune Bullous Disease Swiss Study Group. Mortality of bullous pemphigoid in Switzerland: a prospective study","volume":"165","author":"Cort\u00e9s","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib5","first-page":"305","article-title":"Cutaneous Immunology group of SIDeMaST. Bullous pemphigoid: Italian guidelines adapted from the EDF\/EADV guidelines","volume":"153","author":"Cozzani","year":"2018","journal-title":"G\u00a0Ital Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2022.100129_bib6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.det.2011.06.003","article-title":"Evidence-based management of bullous pemphigoid","volume":"29","author":"Daniel","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.xjidi.2022.100129_bib7","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/j.1365-2133.2011.10531.x","article-title":"Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study","volume":"165","author":"Du-Thanh","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bjd.13717","article-title":"Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology","volume":"172","author":"Feliciani","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib9","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJM199511303332207","article-title":"Management of acquired bullous skin diseases","volume":"333","author":"Fine","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xjidi.2022.100129_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/bmj.1.5741.144","article-title":"Azathioprine in treatment of bullous pemphigoid","volume":"1","author":"Greaves","year":"1971","journal-title":"Br Med J"},{"key":"10.1016\/j.xjidi.2022.100129_bib11","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0190-9622(99)70084-8","article-title":"Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases","volume":"40","author":"Grundmann-Kollmann","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archderm.1993.01680220061016","article-title":"Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid","volume":"129","author":"Guillaume","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/11310740-000000000-00000","article-title":"Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data","volume":"10","author":"G\u00fcrcan","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib14","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/jid.2012.35","article-title":"Incidence and mortality of bullous pemphigoid in France","volume":"132","author":"Joly","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/archderm.141.6.691","article-title":"Prediction of survival for patients with bullous pemphigoid: a prospective study","volume":"141","author":"Joly","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib16","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/jid.2008.412","article-title":"A\u00a0comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study","volume":"129","author":"Joly","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A\u00a0comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xjidi.2022.100129_bib18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0190-9622(99)70061-7","article-title":"Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence","volume":"41","author":"Jung","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib19","first-page":"CD002292","article-title":"Interventions for bullous pemphigoid","volume":"10","author":"Kirtschig","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xjidi.2022.100129_bib20","first-page":"1137","article-title":"Bullous pemphigoid. The latest in diagnosis, prognosis, and therapy","volume":"134","author":"Korman","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib21","doi-asserted-by":"crossref","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.xjidi.2022.100129_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/bjd.19934","article-title":"Doxycycline in the management of bullous pemphigoid: real-world data from a specialist centre","volume":"185","author":"Micallef","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib23","first-page":"925","article-title":"Treatment of bullous pemphigoid with prednisolone only: 0.75 mg\/kg\/day versus 1.25 mg\/kg\/day. A multicenter randomized study","volume":"111","author":"Morel","year":"1984","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2022.100129_bib24","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0190-9622(94)70227-6","article-title":"Low-dose methotrexate treatment in elderly patients with bullous pemphigoid","volume":"31","author":"Paul","year":"1994","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archderm.134.4.465","article-title":"High risk of death in elderly patients with extensive bullous pemphigoid","volume":"134","author":"Roujeau","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib26","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.138.7.903","article-title":"Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age","volume":"138","author":"Rzany","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib27","first-page":"205","article-title":"Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases","volume":"76","author":"Schmidt","year":"2005","journal-title":"Cutis"},{"key":"10.1016\/j.xjidi.2022.100129_bib28","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4103\/0378-6323.82400","article-title":"Evidence-based treatments for pemphigus vulgaris, pemphigus foliaceus, and bullous pemphigoid: a systematic review","volume":"77","author":"Singh","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.xjidi.2022.100129_bib29","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/bjd.14285","article-title":"Assessment of adherence to topical corticosteroids in patients with bullous pemphigoid","volume":"174","author":"Sobocinski","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib30","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/bjd.15649","article-title":"An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone","volume":"177","author":"Sticherling","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib31","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/jdv.12153","article-title":"Whole body application of a potent topical corticosteroid for bullous pemphigoid","volume":"28","author":"Terra","year":"2014","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2022.100129_bib32","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/1346-8138.15111","article-title":"Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita)","volume":"46","author":"Ujiie","year":"2019","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0190-9622(89)70058-X","article-title":"Treatment of bullous pemphigoid with topical clobetasol propionate","volume":"20","author":"Westerhof","year":"1989","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2022.100129_bib34","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S0140-6736(17)30560-3","article-title":"Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial","volume":"389","author":"Williams","year":"2017","journal-title":"Lancet"}],"container-title":["JID Innovations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026722000376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026722000376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T08:02:29Z","timestamp":1763020949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667026722000376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2667026722000376"],"URL":"https:\/\/doi.org\/10.1016\/j.xjidi.2022.100129","relation":{},"ISSN":["2667-0267"],"issn-type":[{"value":"2667-0267","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How Do Experts Treat Patients with Bullous\u00a0Pemphigoid around the World? An\u00a0International Survey","name":"articletitle","label":"Article Title"},{"value":"JID Innovations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjidi.2022.100129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}],"article-number":"100129"}}